[HTML][HTML] Early Alzheimer's disease pathology in human cortex is associated with a transient phase of distinct cell states

V Gazestani, T Kamath, NM Nadaf, SJ Burris, B Rooney… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Cellular perturbations underlying Alzheimer's disease are primarily studied in human
postmortem samples and model organisms. Here we generated a single-nucleus atlas from …

Basal forebrain cholinergic dysfunction in Alzheimer's disease–interrelationship with β-amyloid, inflammation and neurotrophin signaling

R Schliebs - Neurochemical research, 2005 - Springer
Alzheimer's disease, the most common neurodegenerative disorder of senile dementia, is
characterized by two major morpho-pathological hallmarks. Deposition of extracellular …

Targeting synaptic dysfunction in Alzheimer's disease therapy

R Nisticò, M Pignatelli, S Piccinin, NB Mercuri… - Molecular …, 2012 - Springer
In the past years, major efforts have been made to understand the genetics and molecular
pathogenesis of Alzheimer's disease (AD), which has been translated into extensive …

Locus coeruleus integrity and left frontoparietal connectivity provide resilience against attentional decline in preclinical alzheimer's disease

J Pahl, PC Prokopiou, E Bueichekú, AP Schultz… - Alzheimer's Research & …, 2024 - Springer
Autopsy work reported that neuronal density in the locus coeruleus (LC) provides neural
reserve against cognitive decline in dementia. Recent neuroimaging and pharmacological …

Conserved cell-type specific signature of resilience to Alzheimer's disease nominates role for excitatory intratelencephalic cortical neurons

MA Telpoukhovskaia, N Hadad, B Gurdon, Y Dai… - bioRxiv, 2022 - biorxiv.org
Summary Alzheimer's disease (AD), the leading cause of dementia, affects millions of
people worldwide. With no disease-modifying medication currently available, the human toll …

Medial prefrontal cortex pyramidal neurons exhibit functional defects during early stage of Alzheimer's disease in 3xTg‐AD mice

N Choudhury, L Chen, VT Nguyen… - Alzheimer's & …, 2021 - Wiley Online Library
Background The brain regions that show early increase of beta‐amyloid (Aβ) in Alzheimer's
disease (AD) overlap with the default mode network (DMN)(Palmqvist, S. et. al., 2017) …

Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease

SWY Tsang, J Pomakian, GA Marshall, HV Vinters… - Neurobiology of …, 2007 - Elsevier
There are few studies on the clinical and neurochemical correlates of postsynaptic
cholinergic dysfunction in Alzheimer's disease (AD). We have previously found that …

Reply: Optimal use of cholinergic drugs in Alzheimer's disease

H Hampel, E Cavedo, A Vergallo… - Brain, 2018 - academic.oup.com
Sir, We agree with the suggestions of Gauthier and colleagues (Gauthier et al., 2018) for a
more structured approach to therapy in Alzheimer's disease. We also agree that there is …

When acetylcholine unlocks feedback inhibition in cortex

Q Chevy, A Kepecs - Neuron, 2018 - cell.com
Acetylcholine promotes cognitive function through the regulation of cortical circuits. In this
issue of Neuron, Urban-Ciecko et al.(2018) demonstrate how this neuromodulator can …

Neuromodulatory control of hippocampal function: towards a model of Alzheimer's disease

ED Menschik, LH Finkel - Artificial intelligence in medicine, 1998 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of cognitive function
whose cellular pathology and molecular etiology have been increasingly and dramatically …